Zefia Watson

Bachelor of Medicine and Bachelor of Science,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Career Advice and Mentoring Scientific Writing Hospital-Pharmacy-Insurance Journal Manuscript IT-Web-Mobile Technology

Areas Of Interest

Ribosome Inactivating Proteins Gait Ataxias, Sensory p150(Glued) MutS Homolog 2 Protein Petunia Carbohydrate Antigens, Cancer-Associated Transcription Factor, TFIIH Care, Preventive Munc18-1 Protein Receptors, IL 2 Microsome Diperchlorate, Hexamethonium Galega orientali Xeroderma Pigmentosum-A Protein Root Nodulation, Plant Salsoline Alkaloids NuGemfibrozil Aspartate, Ammonium Carbon-Sulfur Ligases Communication, Neuroimmune Interstellar Dusts Phenylketonuria II Scintigraphies, Equilibrium Eicosamethyl Octacontanonadecasen-1-o1 Sea Basses Alogias Vocal Melody beta-Glucosidase Stimulating Protein Secondary Hypothyroidism Receptors, Imidazoline Guanidinium Antiperspirant Spindle, Mitotic

Professional Narrative

Dr. Zefia Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Mayo Clinic 2003
Assistant Professor, Harvard Med 1999

Education

Director Medicine, Baylor College 2009
Doctor of osteopathic medicine, Harvard Medical School 1995

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02